{
  "id": "5c85234775a4a5d219000007",
  "type": "factoid",
  "question": "What antibiotic is currently used as the standard of care for Clostridium Difficile infection as of 2018",
  "ideal_answer": "Fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection. Fidaxomicin is a new antibiotic used to treat Clostridium difficile infection (CDI).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27601193",
    "http://www.ncbi.nlm.nih.gov/pubmed/28009682"
  ],
  "snippets": [
    {
      "text": " Fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27601193",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Fidaxomicin is a new antibiotic used to treat Clostridium difficile infection (CDI). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28009682",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28009682",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Fidaxomicin"
}